Is chemotherapy the standard for asymptomatic androgen-independent prostate cancer?

被引：2
|
作者：
Nabhan, Chadi [1 ]
机构：
[1] Lutheran Gen Hosp, Oncol Specialists SC, Park Ridge, IL 60068 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 14期
关键词：
D O I：
10.1200/JCO.2008.16.6124
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：2413 / 2414
页数：3
相关论文
共 50 条
  • [41] Signal transduction targets in androgen-independent prostate cancer
    Zhou, J
    Scholes, J
    Hsieh, JT
    CANCER AND METASTASIS REVIEWS, 2001, 20 (3-4) : 351 - 362
  • [42] A new weapon against androgen-independent prostate cancer
    Kent, H
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1999, 161 (04) : 364 - 364
  • [43] Androgen-independent prostate cancer progression in the TRAMP model
    Gingrich, JR
    Barrios, RJ
    Kattan, MW
    Nahm, HS
    Finegold, MJ
    Greenberg, NM
    CANCER RESEARCH, 1997, 57 (21) : 4687 - 4691
  • [44] Is ''off-protocol'' chemotherapy for androgen-independent carcinoma of prostate warranted?
    Mani, S
    Vogelzang, NJ
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1996, 10 (03) : 749 - +
  • [45] Amplification of the androgen receptor may not explain the development of androgen-independent prostate cancer
    Edwards, J
    Krishna, NS
    Mukherjee, R
    Watters, AD
    Underwood, MA
    Bartlett, JMS
    BJU INTERNATIONAL, 2001, 88 (06) : 633 - 637
  • [46] Lef1 Expression in Androgen-Independent Prostate Cancer
    Zhang, M.
    Li, Y. R.
    Wang, L. G.
    Melamed, J.
    Liu, X. M.
    Wei, J. J.
    Peng, Y.
    Pellicer, A.
    Garabedian, M. J.
    Ferrari, A.
    Lee, P.
    LABORATORY INVESTIGATION, 2009, 89 : 203A - 203A
  • [47] Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer
    Altundag, K
    Altundag, O
    Morandi, P
    Gunduz, M
    UROLOGY, 2005, 65 (01) : 211 - 212
  • [48] The potential for neurocognitive toxicity in the treatment of androgen-independent prostate cancer
    Garofalo, J.
    Heinige-Kenworthy, T.
    Beer, T.
    PSYCHO-ONCOLOGY, 2007, 16 (03) : S70 - S70
  • [49] Thalidomide/estramustme/pacfitaxel in metastatic androgen-independent prostate cancer
    Mathew, Paul
    Logothetis, Christopher J.
    Dieringer, Pauline Y.
    Chen, Isan
    Pagliaro, Lance C.
    Bekele, Benjamin N.
    Zhou, Man
    Daliani, Danai D.
    CLINICAL GENITOURINARY CANCER, 2006, 5 (02) : 144 - 149
  • [50] Molecular biology of androgen-independent prostate cancer: the role of the androgen receptor pathway
    Mellado, Begona
    Codony, Jordi
    Ribal, Maria Jose
    Visa, Laura
    Gascon, Pere
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (01): : 5 - 10
12345